247 related articles for article (PubMed ID: 25773555)
1. Effect of adherence and insulin delivery system on clinical and economic outcomes among patients with type 2 diabetes initiating insulin treatment.
Ayyagari R; Wei W; Cheng D; Pan C; Signorovitch J; Wu EQ
Value Health; 2015 Mar; 18(2):198-205. PubMed ID: 25773555
[TBL] [Abstract][Full Text] [Related]
2. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
3. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.
Cobden D; Lee WC; Balu S; Joshi AV; Pashos CL
Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200
[TBL] [Abstract][Full Text] [Related]
4. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
[TBL] [Abstract][Full Text] [Related]
5. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.
Cheen HH; Lim SH; Huang MC; Bee YM; Wee HL
Clin Ther; 2014 Jul; 36(7):1043-53. PubMed ID: 24913030
[TBL] [Abstract][Full Text] [Related]
6. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
7. Effect of exenatide, pen insulin, and vial insulin on patient outcomes: a retrospective database analysis of persistence and first-year costs in a commercially insured population.
Rashid N; McCombs JS; Schwartz E
Clin Ther; 2012 May; 34(5):1145-58. PubMed ID: 22464691
[TBL] [Abstract][Full Text] [Related]
8. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007; 29 Spec No():1294-305. PubMed ID: 18046929
[TBL] [Abstract][Full Text] [Related]
9. Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus.
Xie L; Zhou S; Wei W; Gill J; Pan C; Baser O
Diabetes Technol Ther; 2013 Mar; 15(3):230-6. PubMed ID: 23336845
[TBL] [Abstract][Full Text] [Related]
10. Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies.
Xie L; Wei W; Pan C; Baser O
J Med Econ; 2013 Sep; 16(9):1137-45. PubMed ID: 23859434
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial.
Grabner M; Chu J; Raparla S; Quimbo R; Zhou S; Conoshenti J
Postgrad Med; 2013 May; 125(3):204-13. PubMed ID: 23748521
[TBL] [Abstract][Full Text] [Related]
12. Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vials.
Asche CV; Luo W; Aagren M
Curr Med Res Opin; 2013 Oct; 29(10):1287-96. PubMed ID: 23865725
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care setting.
Davis SN; Wei W; Garg S
Endocr Pract; 2011; 17(6):845-52. PubMed ID: 21550952
[TBL] [Abstract][Full Text] [Related]
14. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK
Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Rapid-Acting Insulins in Adults with Diabetes.
Racsa PN; Meah Y; Ellis JJ; Saverno KR
J Manag Care Spec Pharm; 2017 Mar; 23(3):291-298. PubMed ID: 28230457
[TBL] [Abstract][Full Text] [Related]
16. Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study.
Edelman SV; Ermakova A; Xiong Y; Sieradzan R; Taylor SD
J Manag Care Spec Pharm; 2019 Dec; 25(12):1420-1431. PubMed ID: 31550190
[TBL] [Abstract][Full Text] [Related]
17. Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus.
Raval AD; Nguyen MH; Zhou S; Grabner M; Barron J; Quimbo R
J Manag Care Spec Pharm; 2019 Oct; 25(10):1111-1123. PubMed ID: 31556817
[TBL] [Abstract][Full Text] [Related]
18. Comparison of utilization, cost, adherence, and hypoglycemia in patients with type 2 diabetes initiating rapid-acting insulin analog with prefilled pen versus vial/syringe.
Lee LJ; Li Q; Reynolds MW; Pawaskar MD; Corrigan SM
J Med Econ; 2011; 14(1):75-86. PubMed ID: 21231863
[TBL] [Abstract][Full Text] [Related]
19. Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis.
Pelletier EM; Pawaskar M; Smith PJ; Best JH; Chapman RH
J Med Econ; 2012; 15(6):1039-50. PubMed ID: 22533526
[TBL] [Abstract][Full Text] [Related]
20. Considerations for diabetes: treatment with insulin pen devices.
Cuddihy RM; Borgman SK
Am J Ther; 2013; 20(6):694-702. PubMed ID: 21768872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
